| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: Results of a prospective multicenter trial
|
Storrow, Alan B.
|
|
2015
|
48 |
4-5 |
p. 260-267
8 p.
|
artikel
|
| 2 |
Analytical evaluation of point of care cTnT and clinical performances in an unselected population as compared with central laboratory highly sensitive cTnT
|
Dupuy, Anne Marie
|
|
2015
|
48 |
4-5 |
p. 334-339
6 p.
|
artikel
|
| 3 |
An approach to rule-out an acute cardiovascular event or death in emergency department patients using outcome-based cutoffs for high-sensitivity cardiac troponin assays and glucose
|
Shortt, Colleen
|
|
2015
|
48 |
4-5 |
p. 282-287
6 p.
|
artikel
|
| 4 |
A new ultra-high sensitivity troponin I assay for chest pain patients with no evidence of troponin I using a conventional assay
|
Wu, Alan H.B.
|
|
2015
|
48 |
4-5 |
p. 358-359
2 p.
|
artikel
|
| 5 |
B-type natriuretic peptide secretion without change in intra-cardiac pressure
|
Puelacher, Christian
|
|
2015
|
48 |
4-5 |
p. 318-321
4 p.
|
artikel
|
| 6 |
Cardiac biomarkers — A short biography
|
Collinson, Paul O.
|
|
2015
|
48 |
4-5 |
p. 197-200
4 p.
|
artikel
|
| 7 |
Challenges in harmonizing integrated healthcare network laboratories: Multi-center evaluation of the AccuTnI+3 troponin assay
|
Greene, Dina N.
|
|
2015
|
48 |
4-5 |
p. 268-274
7 p.
|
artikel
|
| 8 |
Chimeric recombinant antibody fragments in cardiac troponin I immunoassay
|
Hyytiä, Heidi
|
|
2015
|
48 |
4-5 |
p. 347-352
6 p.
|
artikel
|
| 9 |
Combining presentation high-sensitivity cardiac troponin I and glucose measurements to rule-out an acute myocardial infarction in patients presenting to emergency department with chest pain
|
Greenslade, J.H.
|
|
2015
|
48 |
4-5 |
p. 288-291
4 p.
|
artikel
|
| 10 |
Comprehensive biomarker profiling in patients with obstructive sleep apnea
|
Maeder, Micha T.
|
|
2015
|
48 |
4-5 |
p. 340-346
7 p.
|
artikel
|
| 11 |
Decreasing troponin turnaround time in the emergency department using the central laboratory: A process improvement study
|
Boelstler, Arlene M.
|
|
2015
|
48 |
4-5 |
p. 308-312
5 p.
|
artikel
|
| 12 |
Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trial
|
Storrow, Alan B.
|
|
2015
|
48 |
4-5 |
p. 254-259
6 p.
|
artikel
|
| 13 |
Dynamic changes in sRAGE levels and relationship with cardiac function in STEMI patients
|
Jensen, Louise J.N.
|
|
2015
|
48 |
4-5 |
p. 297-301
5 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2015
|
48 |
4-5 |
p. i-
1 p.
|
artikel
|
| 15 |
Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices™ systematic review
|
Layfield, Christopher
|
|
2015
|
48 |
4-5 |
p. 204-212
9 p.
|
artikel
|
| 16 |
Evidence based application of BNP/NT-proBNP testing in heart failure
|
Don-Wauchope, Andrew C.
|
|
2015
|
48 |
4-5 |
p. 236-246
11 p.
|
artikel
|
| 17 |
High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease
|
Bjurman, Christian
|
|
2015
|
48 |
4-5 |
p. 302-307
6 p.
|
artikel
|
| 18 |
How acute changes in cardiac troponin concentrations help to handle the challenges posed by troponin elevations in non-ACS-patients
|
Wildi, Karin
|
|
2015
|
48 |
4-5 |
p. 218-222
5 p.
|
artikel
|
| 19 |
IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays
|
Apple, Fred S.
|
|
2015
|
48 |
4-5 |
p. 201-203
3 p.
|
artikel
|
| 20 |
PAPP-A and IGFBP-4 fragment levels in patients with ST-elevation myocardial infarction treated with heparin and PCI
|
Hjortebjerg, Rikke
|
|
2015
|
48 |
4-5 |
p. 322-328
7 p.
|
artikel
|
| 21 |
Prognostic significance of active and modified forms of endothelin 1 in patients with heart failure with reduced ejection fraction
|
Gottlieb, Stephen S.
|
|
2015
|
48 |
4-5 |
p. 292-296
5 p.
|
artikel
|
| 22 |
Reviewer Acknowledgement
|
|
|
2015
|
48 |
4-5 |
p. 360-362
3 p.
|
artikel
|
| 23 |
Skeletal troponin I cross-reactivity in different cardiac troponin I assay versions
|
Hyytiä, Heidi
|
|
2015
|
48 |
4-5 |
p. 313-317
5 p.
|
artikel
|
| 24 |
The clinical and diagnostic performance characteristics of the high sensitivity Abbott cardiac troponin I assay
|
Collinson, P.O.
|
|
2015
|
48 |
4-5 |
p. 275-281
7 p.
|
artikel
|
| 25 |
The economics of cardiac biomarker testing in suspected myocardial infarction
|
Goodacre, Steve
|
|
2015
|
48 |
4-5 |
p. 213-217
5 p.
|
artikel
|
| 26 |
The predictive potential of asymptomatic mild elevation of cardiac troponin I on mortality risk of stable patients with vascular disease
|
Mayer Jr., Otto
|
|
2015
|
48 |
4-5 |
p. 353-357
5 p.
|
artikel
|
| 27 |
Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction
|
Parikh, Ravi H.
|
|
2015
|
48 |
4-5 |
p. 247-253
7 p.
|
artikel
|
| 28 |
Usefulness of S100A12 as a prognostic biomarker for adverse events in patients with heart failure
|
He, Yun-Yun
|
|
2015
|
48 |
4-5 |
p. 329-333
5 p.
|
artikel
|
| 29 |
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity
|
Christenson, Eric S.
|
|
2015
|
48 |
4-5 |
p. 223-235
13 p.
|
artikel
|
Tijdschrift beschrijving